Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro

Toxicology and Applied Pharmacology

Volumn 145, Issue 1, 1997, Pages 91-98

  Flint, Oliver P ^a   Masters, Barbara A ^a   Gregg, Richard E ^b   Durham, Stephen K ^b  

^a BRISTOL MYERS SQUIBB COMPANY   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BMS 187745; BMS 188494; FARNESOL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVALONIC ACID; MEVINOLIN; PRAVASTATIN; SQUALENE; SQUALENE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; MORPHOLOGY; MYOPATHY; NONHUMAN; PROTEIN SYNTHESIS; RAT; SKELETAL MUSCLE;

ANIMALIA;

EID: 0031194174     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1997.8131     Document Type: Article

References (44)

1. Agnew W. S. Squalene synthetase. Methods Enzymol. 110:1985;359-373.
2. Anderson D. M., Goyle S., Phillips B. J., Tee A., Beech L., Butler W. H. Effects of methylisocyanate on rat muscle cells in culture. Br. J. Ind. Med. 45:1988;269-274.
3. Barrett J. N., Barrett E. F., Dribin L. B. Calcium-dependent slow potassium conductance in rat skeletal myotubes. Dev. Biol. 82:1981;258-266.
4. Bergstrom D., Kurtz M. M., Rew D. J., Amend A. M., Karkas J. D., Bostedor R. G., Bansal V. S., Dufresne C., Vanmiddlesworth F. L., Hensens O. D., Leisch J. M., Zink D. L., Wilson K. E., Onishi J., Milligan J. A., Bills G., Kaplan L., Nallin Omstead M., Jenkins R. G., Huang L., Meinz M. S., Quinn L., Burg R. W., Kong Y. L., Mochales S., Mojena M., Martin I., Pelaez F., Diez M. T., Alberts A. W. Zaragozic acids: A family of fungal metabolites that are picomolar competitive inhibitors of squalene synthase. Proc. Natl. Acad. Sci. USA. 90:1993;80-84.
5. Bischoff R. Proliferation of muscle satellite cells on intact myofibers in culture. Dev. Biol. 115:1986;129-139.
6. Bligh E. G., Dyer W. J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:1959;911-917.
7. Corsini A., Raiteri M., Soma M., Fumagalli R., Paoletti R. Simvastatin, but not pravastatin inhibits the proliferation of rat aorta myocytes. Pharmacol. Res. 23:1991;173-180.
8. Cossu G., Zani B., Coletta M., Bouché M., Pacifici M., Molinaro M. In vitro. Cell Differ. 9:1980;357-368.
9. Cox A. D., Hisaka M. M., Buss J. E., Der C. J. Specific isoprenoid modification is required for functional, by not oncogenic, Ras protein. Mol. Cell Biol. 12:1992;2606-2615.
10. Dickson J. K. Jr., Biller S. A., Magnin D. R., Petrillo E. W. Jr., Hillyer J. W., Hsieh D. C., Lan S. J., Rinehart J. K., Gregg R. E., Harrity T. W., Jolibois K. G., Kalinowski S. S., Kunselman L. K., Mookhtiar K. A., Ciosek C. P. Jr. Orally active squalene synthase inhibitors: Bis((acyloxy)alkyl) prodrugs of the a-phosphonosulfonic acid moiety. J. Med. Chem. 39:1996;661-664.
11. Epstein W. W., Lever D., Leining L. M., Bruenger E., Rilling H. C. Quantitation of prenylcysteines by a selective cleavage reaction. Proc. Natl. Acad. Sci. USA. 88:1991;9668-9670.
12. Goldstein J. L., Brown M. S. Regulation of the mevalonate pathway. Nature. 343:1990;425-430.
13. Hancock J. F., Cadwallader K., Paterson H., Marshall C. J. A CAAX or a CAAL motif and a second signal are sufficient for plasma membrane targeting of Ras proteins. EMBO J. 10:1991;4033-4039.
14. Hesketh J. E., Whitelaw P. F. The role of cellular oncogenes in myogenesis and muscle cell hypertrophy. Int. J. Biochem. 24:1992;193-203.
15. Jacobs A. E. M., Benders A. A. G. M., Oosterhof A., Verkamp J. H. Effects of growth medium, electrical stimulation and paralysis of various enzyme activities in cultured rat muscle cells. Comparison with activities in rat musclesin vivo. Int. J. Biochem. 24:1992;751-758.
16. Jones P. H. In vitro. Exp. Cell Res. 139:1982;401-404.
17. Kato I., Harihara A., Mizushima Y. Anin vitro. Toxicol. Appl. Pharmacol. 117:1992;194-199.
18. Kim R., Rine J., Kim S. H. Prenylation of mammalian Ras protein in Xenopus oocytes. Mol. Cell. Biol. 10:1990;5945-5949.
19. Lerner S., Haklai R., Kloog Y. Isoprenylation and carboxymethylation in small GTP-binding proteins of pheochromocytoma (PC-12) cells. Cell. Mol. Neurobiol. 12:1992;333-351.
20. Magnin D. R., Biller S. A., Chen Y., Dickson J. K. Jr., Fryszman O. M., Lawrence R. M., Logan J. V. H., Sieber-McMaster E. S., Sulsky R. B., Traeger S. C., Hsieh D. C., Lan S. J., Rinehart J. K., Harrity T. W., Jolibois K. G., Kunselman L. K., Rich L. C., Slusarchyk D. A., Ciosek C. P. Jr. α-Phosphonosulfonic acids: Potent and selective inhibitors of squalene synthase. J. Med. Chem. 39:1996;657-660.
21. Maltese W. A., Sheridan K. M. Isoprenylated proteins in cultured cells: Subcellular distribution and changes related to altered morphology and growth arrest induced by mevalonate deprivation. J. Cell. Physiol. 133:1987;471-481.
22. Masters B. A., Palmoski M. J., Flint O. P., Gregg R. E., Wang-Iverson D., Durham S. K. In vitro. Toxicol. Appl. Pharmacol. 131:1995;163-174.
23. Nag A., Foster J. D. Myogenesis in adult mammalian skeletal musclein vitro. J. Anat. 132:1981;1-18.
24. O'Donnell M. P., Kasiske B. L., Kim Y., Atluru D., Keane W. F. Lovastatin inhibits proliferation of rat mesangial cells. J. Clin. Invest. 1:1993;83-87.
25. Pardridge W. M., Duducgian-vartavarian L., Casanello-erti D., Jones M., Kopple J. D. Glucose and amino acid metabolism in neonatal rat skeletal muscle in tissue culture. J. Cell. Physiol. 102:1980;91-98.
26. Plumb J. Culture of specific cell types. Culture of Animal Cells. 1987;A. R. Liss, New York. p. 271-272.
27. Reddy N. B., Askanas V., Oliver K. L., Lawrence J. V., Carter L., Engel W. K. Biochemical and morphological effects of 20,25-Diazacholesterol on cultured muscle cells. Biochem. Pharmacol. 31:1982;91-97.
28. Repko E. M., Maltese W. A. Post-translational isoprenylation of cellular proteins is altered in response to mevalonate availability. J. Biol. Chem. 264:1989;9945-9952.
29. Reiger F., Koenig J., Vigny M. Spontaneous contractile activity and the presence of the 16 S form of acetylcholinesterase in rat muscle cells in culture: Reversible suppressive action of tetrodotoxin. Dev. Biol. 76:1980;358-365.
30. Rilling H. C., Bruenger E., Leining L. M., Buss J. E., Epstein W. W. Differential prenylation of proteins as a function of mevalonate concentration in CHO cells. Arch. Biochem. Biophys. 301:1993;210-215.
31. Roeder R. A., Gunn J. M. Effects of zeranol on protein turnover in L6 myotubes. Domest. Anim. Endocrinol. 4:1987;61-67.
32. Russell D. W. Cholesterol biosynthesis and metabolism. Cardiovasc. Drugs Ther. 6:1992;103-110.
33. Sasson S., Cerasi E. Substrate regulation of the glucose transport system in rat skeletal muscle. J. Biol. Chem. 261:1986;16827-16833.
34. Schultz B., Lipton B. H. The effect of marcaine on muscle and non-muscle cellin vitro. Anat. Rec. 191:1978;351-370.
35. Shainberg A., Gamliel A., Schreiber G. Trifluoperazine and phencyclidine inhibit synergistically carbamylcholine-induced cation influx in muscle cultures. Shahar A., Goldberg A. M. Model Systems in Neurotoxicology: Alternative Approaches to Animal Testing. 1987;287-301 A. R. Liss, New York.
36. H. Shindo, K. Kawau, K. Fukuda, M. Matsumura, K. Tanaka, M. Tanaka, T. Yokota, 1973, Proceedings, The Fifth Symposium on Drug Metabolism and Action, 49, 66.
37. +. Nature. 287:1980;447-449.
38. Smith P. K., Krohn R. I., Hermanson G. T., Mallia A. K., Gartner F. H., Provenzano M. D., Fujimoto E. K., Goeke N. M., Olson B. J., Klenk D. C. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150:1985;76-85.
39. Smith P. S., Eydelloth R. S., Grossman S. J., Stubbs R. J., Schwartz M. S., Germershausen J. I., Vyas K. P., Kari P. H., Macdonald J. S. HMG-CoA reductase inhibitor-induced myopathy in the rat: Cyclosporine A interaction and mechanism studies. J. Pharmacol. Exp. Ther. 257:1991;1225-1235.
40. Smith P. F., Eydelloth R. S., Grossman S. J., Stubbs R. J., Schwartz M. S., Germershausen J. I., Macdonald J. S. Myopathy associated with HMG-CoA reductase inhibitors (HMGRIs) and cyclosporin A: Evaluation in a rat model. Eur. Heart J. 13:1992;2-6.
41. Soma M. R., Corsini A., Paoletti R. Cholesterol and mevalonic acid modulation in cell metabolism and multiplication. Toxicol. Lett. 64/65:1992;1-15.
42. Trupin G. I., Hsu L., Parfett G. An autoradiographic study of the role of satellite cells and myonuclei during myogenesisin vitro. Virchows Arch. [Cell Pathol.]. 39:1982;339-349.
43. Williams P. D., Masters B. A., Evans L. D., Laska D. A., Hottendorf G. H. Anin vitro. Fundam. Appl. Toxicol. 9:1987;1-17.
44. Yaffe D. Preparation of primary cultures: Rat skeletal muscle cells. Kruse P. F., Patterson M. K. Tissue Culture Methods and Applications. 1973;106-114 Academic Press, New York.